This inventor holds 9 USPTO granted patents. Top assignee: Beecham Pharmaceuticals (Pte) Limited. Active years: 2001-2007.
Company Filing History:
Years Active: 2001-2007
Title: The Innovative Mind of John A. Roush
Introduction
John A. Roush, an accomplished inventor based in Kingsport, Tennessee, has made significant contributions to the field of pharmaceuticals. With a total of nine patents to his name, he has focused much of his work on the treatment of bacterial infections, leveraging his expertise to develop innovative solutions that can benefit countless individuals.
Latest Patents
Among his notable patents, Roush's most recent innovations include methods for treating bacterial infections. One patent details a high dosage regimen of amoxicillin and potassium clavulanate, which is particularly noteworthy for the use of a bilayer tablet to enhance delivery and efficacy. Additionally, Roush has developed compositions and methods of treatment that combine these same antibiotics with xanthan, further emphasizing his commitment to advancing pharmaceutical treatments for bacterial infections.
Career Highlights
Roush’s career is distinguished by his tenure at Beecham Pharmaceuticals (Pte) Limited, a company known for its strong dedication to developing effective therapeutic solutions. His work has positioned him as a thoughtful innovator in the pharmaceutical industry, addressing critical healthcare challenges through his research and patented inventions.
Collaborations
Throughout his career, John A. Roush has worked alongside esteemed colleagues, including Creighton P. Conley and Kevin H. Storm. These collaborations have allowed for a rich exchange of ideas and have undoubtedly influenced the direction of their projects aimed at enhancing treatment methodologies.
Conclusion
John A. Roush exemplifies the spirit of innovation that drives progress in the pharmaceutical realm. His patents not only reflect his creativity but also his commitment to improving treatment options for bacterial infections. As he continues his work at Beecham Pharmaceuticals, the impact of his inventions is likely to resonate within the medical community and beyond.